Enliven Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $3.8M | 98k | 39.21 |
| 2025-12-31 | $367k | 24k | 15.42 |
| 2025-09-30 | $4.7M | 231k | 20.47 |
| 2025-06-30 | $11M | 528k | 20.06 |
| 2025-03-31 | $319k | 16k | 19.74 |
| 2024-12-31 | $307k | 14k | 22.53 |
| 2024-09-30 | $298k | 12k | 25.59 |
| 2024-06-30 | $262k | 11k | 23.38 |